Special session
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Room
Auditorium 1A
Chairs
- Susana Banerjee (London, United Kingdom)
- Nicole Concin (Innsbruck, Austria)
Session Description
To view the Session Chair DOI click here
Clinical trial highlights
Special session
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase III trial
Lecture Time
10:30 - 10:40
Speakers
- Ning Li (Beijing, China)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
ATHENA (GOG-3020/ENGOT-ov45): A randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Lecture Time
10:40 - 10:50
Speakers
- Rebecca Kristeleit (London, United Kingdom)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
Invited Discussant of PRIME and ATHENA-MONO studies
Lecture Time
10:50 - 11:05
Speakers
- Mansoor Raza Mirza (Copenhagen, Denmark)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
Live Q&A
Lecture Time
11:05 - 11:15
Speakers
- Susana Banerjee (London, United Kingdom)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer
Lecture Time
11:15 - 11:25
Speakers
- Vicky Makker (New York City, NY, United States of America)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
MITO 23: A randomized phase III trial on trabectedin vs physician choice chemotherapy in BRCA mut and BRCAness ovarian cancer
Lecture Time
11:25 - 11:35
Speakers
- Domenica Lorusso (Rome, Italy)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
Invited Discussant of SIENDO/ENGOT-EN5 and MITO 23 studies
Lecture Time
11:35 - 11:50
Speakers
- Isabelle L. Ray-Coquard (Lyon, France)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights
Special session
Live Q&A
Lecture Time
11:50 - 12:00
Speakers
- Susana Banerjee (London, United Kingdom)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00